(Q41544264)

3 October 2017

Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type (English)

1 reference

3 October 2017

Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in adults with attention deficit disorder, residual type (English)

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

attention deficit hyperactivity disorder

27 August 2023

main subject

cerebrospinal fluid

0 references

1 reference

F. W. Reimherr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200893

27 August 2023

P. H. Wender

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200893

27 August 2023

M. H. Ebert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200893

27 August 2023

D. R. Wood

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6200893

27 August 2023

language of work or name

English

0 references

publication date

1 January 1984

1 reference

full work available at URL

3 October 2017

https://api.elsevier.com/content/article/PII:0165178184901094?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

https://api.elsevier.com/content/article/PII:0165178184901094?httpAccept=text/plain

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

27 August 2023

1 reference

3 October 2017

11

1 reference

3 October 2017

1

1 reference

3 October 2017

71-78

1 reference

Hyperkinetic adult. Study of the "paradoxical" amphetamine response

3 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Neurochemical investigation of an endogenous model of the “hyperkinetic syndrome” in a hybrid dog

27 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Biologic heterogeneity and psychiatrict research. Platelet MAO activity as a case study

27 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Paradoxical response to amphetamine in a hyperkinetic adult

27 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

The identification and treatment of adult brain dysfunction.

27 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report.

27 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine.

27 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction

27 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Central monoamines and hyperkinase of childhood

27 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment

27 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

27 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(84)90109-4

27 August 2023

Identifiers

1 reference

3 October 2017

1 reference